News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
898,450 Results
Type
Article (89697)
Company Profile (664)
Press Release (808067)
Multimedia
Podcasts (284)
Webinars (44)
Section
Business (267525)
Career Advice (4177)
Deals (40167)
Drug Delivery (246)
Drug Development (92161)
Employer Resources (212)
FDA (18744)
Job Trends (17566)
News (399655)
Policy (40038)
Tag
2025 Best Places to Work (26)
2026 Best Places to Work (40)
2027 BioCapital Standard (5)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (9)
2027 Biotech Beach Standard (6)
2027 Genetown Elite (2)
2027 Genetown Standard (6)
2027 NextGen (5)
2027 Pharm Country Digital (4)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (5)
40 Under 40 (4)
Academia (3112)
Academic (2)
Accelerated approval (77)
ADA (54)
Adcomms (44)
Allergies (237)
Alliances (57000)
ALS (293)
Alzheimer's disease (2165)
Antibody-drug conjugate (ADC) (784)
Approvals (19345)
Artificial intelligence (1153)
ASCO (350)
Autoimmune disease (541)
Automation (84)
Bankruptcy (414)
Belgium (45)
Best Places to Work (12636)
BIO (84)
Biologics (121)
BIOSECURE Act (23)
Biosimilars (309)
BioSpace Insights (271)
Biotechnology (340)
Bispecific (62)
Bladder cancer (253)
Brain cancer (105)
Breast cancer (986)
Cancer (8103)
Cardiovascular disease (689)
Career advice (3640)
Career pathing (65)
CAR-T (466)
CDC (82)
CDMO (239)
Celiac Disease (7)
Cell-line development (2)
Cell therapy (1286)
Cervical cancer (69)
Clinical research (81292)
Collaboration (2902)
Commercialization (77)
Company closure (10)
Compensation (1948)
Complete response letters (129)
COVID-19 (3089)
CRISPR (155)
CRO (10)
C-suite (1719)
Cystic fibrosis (183)
Data (11232)
Decentralized trials (4)
Denatured (112)
Depression (230)
Dermatology (209)
Diabetes (856)
Diagnostics (7956)
Digital health (88)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (570)
Drug pricing (255)
Drug shortages (41)
Duchenne muscular dystrophy (389)
Earnings (104826)
Editorial (85)
Employer branding (27)
Employer resources (184)
ESMO (441)
Events (142053)
Executive appointments (1386)
Eye disease (28)
FDA (23896)
Fibrodysplasia Ossificans Progressiva (17)
Fragile X (6)
Friedreich's ataxia (29)
Frontotemporal dementia (43)
Funding (2399)
Gene editing (323)
Generative AI (116)
Gene therapy (994)
GLP-1 (1419)
Government (5638)
Grass and pollen (8)
Guidances (446)
Healthcare (21528)
Hematology (239)
HIV (128)
Huntington's disease (93)
Idiopathic pulmonary fibrosis (16)
IgA nephropathy (155)
Immunology and inflammation (433)
Immuno-oncology (166)
Indications (299)
Infectious disease (3551)
Inflammatory bowel disease (285)
Inflation Reduction Act (17)
Influenza (168)
Intellectual property (392)
Interviews (830)
IPO (18072)
IRA (61)
Job creations (5211)
Job search strategy (2883)
JPM (73)
Kidney cancer (32)
Kidney disease (183)
Labor market (154)
Layoffs (734)
Leadership (70)
Legal (10180)
Licensing (137)
Liver cancer (121)
Longevity (58)
Lung cancer (1117)
Lung diease (27)
Lymphoma (571)
Machine learning (78)
Management (72)
Manufacturing (1668)
Marketing (43)
MASH (260)
Medical affairs (6)
Medical device (15491)
Medtech (15831)
Mergers & acquisitions (23658)
Metabolic disorders (2181)
Middle East (2)
mRNA (347)
Multiple sclerosis (264)
Multispecific (7)
NASH (24)
Netherlands (42)
Neurodegenerative disease (641)
Neuropsychiatric disorders (155)
Neuroscience (4392)
Neurotech (4)
NextGen: Class of 2026 (7718)
Non-profit (5176)
Now hiring (103)
Obesity (1031)
Opinion (411)
Ovarian cancer (302)
Pain (354)
Pancreatic cancer (461)
Parkinson's disease (497)
Partnered (53)
Patents (820)
Patient advocacy (8)
Patient recruitment (988)
Patient selection (122)
Peanut (81)
People (69190)
Peptides (46)
Pharmaceutical (83)
Pharmacy benefit managers (43)
Phase 1 (25071)
Phase 2 (35316)
Phase 3 (26616)
Pipeline (14775)
Policy (435)
Postmarket research (3561)
Preclinical (11219)
Press Release (74)
Prostate cancer (415)
Psychedelics (105)
Radioligand (3)
Radiopharmaceuticals (450)
Rare diseases (1622)
Real estate (7479)
Recruiting (84)
Regenerative medicine (40)
Regulatory (31942)
Reports (104)
Research institute (2824)
Resumes & cover letters (657)
Rett syndrome (60)
RNA editing (39)
RSV (107)
Saudi Arabia (1)
Schizophrenia (231)
Series A (411)
Series B (287)
Series C (1)
Service/supplier (17)
Sickle cell disease (153)
Special edition (38)
Spinal muscular atrophy (201)
Sponsored (61)
Startups (4409)
State (2)
Stem cells (8)
Stomach cancer (24)
Substance use disorders (23)
Supply chain (173)
Switzerland (25)
Tariffs (109)
Tax incentives (2)
The Weekly (169)
Vaccines (1455)
Venture capital (188)
Weight loss (686)
Wet AMD (8)
Women's health (191)
Women in leadership (2)
Worklife (28)
Date
Today (152)
Last 7 days (927)
Last 30 days (4103)
Last 365 days (34030)
2026 (31080)
2025 (33214)
2024 (37866)
2023 (42564)
2022 (53927)
2021 (58720)
2020 (57662)
2019 (51333)
2018 (39119)
2017 (37186)
2016 (38329)
2015 (44431)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1311)
Alabama (118)
Alaska (7)
Arizona (495)
Arkansas (17)
Asia (53227)
Australia (9374)
California (17428)
Canada (4793)
China (2075)
Colorado (776)
Connecticut (778)
Delaware (549)
Europe (122902)
Florida (2642)
Georgia (567)
Hawaii (5)
Idaho (70)
Illinois (1506)
India (158)
Indiana (787)
Iowa (37)
Japan (790)
Kansas (160)
Kentucky (69)
Louisiana (73)
Maine (99)
Maryland (2056)
Massachusetts (12615)
Michigan (477)
Minnesota (958)
Mississippi (8)
Missouri (191)
Montana (38)
Nebraska (31)
Nevada (208)
New Hampshire (94)
New Jersey (4614)
New Mexico (38)
New York (4542)
North Carolina (2253)
North Dakota (14)
Northern California (8903)
Ohio (544)
Oklahoma (32)
Oregon (55)
Pennsylvania (3339)
Puerto Rico (38)
Rhode Island (66)
South America (1674)
South Carolina (105)
South Dakota (2)
Southern California (6950)
Tennessee (291)
Texas (2898)
United States (61778)
Utah (531)
Vermont (2)
Virginia (437)
Washington D.C. (90)
Washington State (1391)
West Virginia (4)
Wisconsin (200)
Wyoming (6)
898,450 Results for "modra pharmaceuticals b v".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Alfasigma to Acquire Nordic Group B.V. Expanding Its Specialty Care Portfolio and Presence in Europe
August 11, 2026
·
4 min read
Press Releases
Nuvectis Reports Positive Data from NXP200 Phase 1b Study Demonstrating Durable Responses, Including Complete Responses, in BRAF V600-mutated Recurrent or Progressive Gliomas
October 26, 2026
·
7 min read
Approvals
GSK, Ionis win FDA nod for hepatitis B functional cure that controls virus after treatment
Hibsago’s approval—a functional cure for certain patients with a hepatitis B infection—further validates Ionis Pharmaceuticals’ antisense platform, which has already generated two other new drug approvals this year.
October 21, 2026
·
3 min read
·
Tristan Manalac
Press Releases
Nurix Therapeutics Appoints Arati V. Rao, M.D., as Chief Medical Officer
November 11, 2026
·
5 min read
Cancer
Roche finds another oncology gem in Asia with $1.5B B cell disease partnership
Roche has tapped Simcere Zaiming for a new T cell engager that could have broad application in B cell–mediated diseases including lymphoma and autoimmune conditions.
September 1, 2026
·
2 min read
·
Annalee Armstrong
Press Releases
Vetter’s V-OVS® next earns prestigious Red Dot Design Concept Award
Novel syringe closure system honored for its innovative design and enhanced user experience · Award recognizes innovative design concept · New syringe closure system builds on more than two decades of market success
October 15, 2026
·
3 min read
Press Releases
Valneva Announces Positive Phase 2 Results for Tetravalent Shigella Vaccine Candidate S4V2
November 9, 2026
·
7 min read
Press Releases
Medicus Pharma to Highlight Rationale for CD228V Co-Development and License Agreement
November 9, 2026
·
17 min read
Press Releases
Vivoryon Therapeutics N.V. Reports Q3 2026 Financial Results and Provides Business Update
November 5, 2026
·
9 min read
Press Releases
Corbus Pharmaceuticals presents Phase 1b CANYON-1 clinical trial data for CRB-913 at ObesityWeek® 2026
November 16, 2026
·
8 min read
1 of 89,845
Next